Skip to content

Labman: what changed

BE 1021.928.454NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved

Only one financial year

Comparing needs two financial years with figures read. This company has one.

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€123 to €123

Midpoint €123 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €123
Indication €123

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€123
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€123

Capitalised earnings

net result for the year (9904)
2025
-€1,877
Average result
-€1,877
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.